• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶插入/缺失(I/D)多态性与糖尿病肾病

ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.

作者信息

Rahimi Zohreh

机构信息

Medical Biology Research Center and Department of Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

J Nephropathol. 2012 Oct;1(3):143-51. doi: 10.5812/nephropathol.8109. Epub 2012 Oct 1.

DOI:10.5812/nephropathol.8109
PMID:24475405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3886156/
Abstract

CONTEXT

Angiotensin converting enzyme (ACE) gene encodes ACE, a key component of renin angiotensin system (RAS), plays an important role in blood pressure homeostasis by generating the vasoconstrictor peptide angiotensin II.

EVIDENCE ACQUISITIONS

Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.

RESULTS

The presence of ACE insertion/deletion (I/D) polymorphism affects the plasma level of ACE. ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in carriers of II genotype.

CONCLUSIONS

In this review focus has been performed on the study of ACE I/D polymorphism in various populations and its influence on the risk of onset and progression of diabetic nephropathy. Also, association between ACE I/D polymorphism and response to ACE inhibitor and angiotensin II receptor antagonists will be reviewed. Further, synergistic effect of this polymorphism and variants of some genes on the risk of development of diabetic nephropathy will be discussed.

摘要

背景

血管紧张素转换酶(ACE)基因编码ACE,肾素血管紧张素系统(RAS)的关键组成部分,通过生成血管收缩肽血管紧张素II在血压稳态中起重要作用。

证据获取

检索了开放获取期刊目录(DOAJ)、谷歌学术、PubMed(美国国立医学图书馆)、LISTA(EBSCO)和科学引文索引。

结果

ACE插入/缺失(I/D)多态性的存在影响ACE的血浆水平。与II基因型携带者中最低的ACE活性相比,ACE DD基因型与最高的全身和肾脏ACE水平相关。

结论

本综述重点研究了不同人群中ACE I/D多态性及其对糖尿病肾病发病和进展风险的影响。此外,还将综述ACE I/D多态性与ACE抑制剂和血管紧张素II受体拮抗剂反应之间的关联。此外,还将讨论这种多态性与某些基因变体对糖尿病肾病发生风险的协同作用。

相似文献

1
ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.血管紧张素转换酶插入/缺失(I/D)多态性与糖尿病肾病
J Nephropathol. 2012 Oct;1(3):143-51. doi: 10.5812/nephropathol.8109. Epub 2012 Oct 1.
2
The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.血管紧张素转换酶基因多态性对马来西亚患者免疫球蛋白A肾病进展的影响。
Singapore Med J. 2008 Nov;49(11):924-9.
3
Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.先兆子痫患者血浆中血管紧张素 -(1 - 7)水平降低和肾素活性降低与血管紧张素转换酶缺失/缺失基因型有关。
Braz J Med Biol Res. 2007 Apr;40(4):583-90. doi: 10.1590/s0100-879x2007000400018.
4
Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.糖尿病与大血管病变中血管紧张素转换酶及纤溶酶原激活物抑制剂-1基因的多态性1
Kidney Int. 1998 Nov;54(5):1659-69. doi: 10.1046/j.1523-1755.1998.00139.x.
5
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.血管紧张素转换酶基因多态性:潜在的沉默子基序及其对IgA肾病进展的影响
Kidney Int. 1996 Feb;49(2):571-7. doi: 10.1038/ki.1996.81.
6
Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.血管紧张素转换酶插入/缺失多态性与糖尿病和非糖尿病肾病中的肾脏保护作用
Clin J Am Soc Nephrol. 2008 Sep;3(5):1511-25. doi: 10.2215/CJN.04140907. Epub 2008 Jun 11.
7
[Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].[血管紧张素转换酶插入/缺失多态性与2型糖尿病患者的血压调节]
Acta Med Croatica. 2011 Oct;65 Suppl 3:14-9.
8
Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.血管紧张素转换酶抑制剂治疗高血压患者时,血清肾素-血管紧张素系统成分浓度与 ACE I/D 多态性的关系。
Clin Exp Hypertens. 2019;41(7):662-669. doi: 10.1080/10641963.2018.1529782. Epub 2018 Oct 11.
9
ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.ACE 变体与 RAS 通路相互作用,导致 2 型糖尿病肾病的发病风险和保护作用。
DNA Cell Biol. 2009 Mar;28(3):141-50. doi: 10.1089/dna.2008.0810.
10
Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.胰岛素依赖型糖尿病患者肾病发生风险因素的评估:血管紧张素转换酶基因插入/缺失多态性、高血压及代谢控制情况
Diabetologia. 1997 Mar;40(3):327-31. doi: 10.1007/s001250050682.

引用本文的文献

1
Correlation of insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients.插入/缺失基因多态性与卡托普利在印度尼西亚高血压患者中的疗效相关性。
Pharmacogenomics. 2024;25(8-9):357-365. doi: 10.1080/14622416.2024.2375190. Epub 2024 Jul 29.
2
Distribution of the ACE Gene Polymorphisms in Type 2 Diabetes Mellitus Patients, Their Associations with Nephropathy Biomarkers and Metabolic Indicators at a Tertiary Hospital in Uganda.乌干达一家三级医院2型糖尿病患者ACE基因多态性的分布及其与肾病生物标志物和代谢指标的关联
Diabetes Metab Syndr Obes. 2024 Jun 5;17:2211-2220. doi: 10.2147/DMSO.S462740. eCollection 2024.
3
The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy.血管紧张素转换酶(ACE)基因多态性在糖尿病肾病发生及治疗风险中的作用
J Clin Med. 2024 Feb 8;13(4):995. doi: 10.3390/jcm13040995.
4
The frequency of the ACE I/D polymorphism in South America: a systematic review and meta-analysis.南美洲 ACE I/D 多态性的频率:系统评价和荟萃分析。
Mol Cell Biochem. 2024 Nov;479(11):2955-2972. doi: 10.1007/s11010-023-04923-9. Epub 2024 Feb 3.
5
Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy.临床和临床前证据表明,血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可预防糖尿病周围神经病变。
Sci Rep. 2024 Jan 10;14(1):1039. doi: 10.1038/s41598-024-51572-z.
6
Effect of the Angiotensin-Converting Enzyme (ACE) (I/D) Polymorphism in COVID-19 Patients and Their Healthy Contacts.血管紧张素转换酶(ACE)(I/D)基因多态性对COVID-19患者及其健康接触者的影响。
Cureus. 2023 May 5;15(5):e38610. doi: 10.7759/cureus.38610. eCollection 2023 May.
7
Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM.胱抑素 C 联合不同 ACE 基因预测 2 型糖尿病患者肾功能不全的诊断效能。
Sci Rep. 2023 Mar 31;13(1):5288. doi: 10.1038/s41598-023-32012-w.
8
The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level.血管紧张素转换酶(ACE)I/D 多态性对非透析慢性肾脏病患者动脉粥样硬化性心血管疾病及心血管死亡风险的影响:血浆 ACE 水平的中介作用。
Genes (Basel). 2022 Jun 23;13(7):1121. doi: 10.3390/genes13071121.
9
Maternal serum proteomic profiles of pregnant women with type 1 diabetes.1 型糖尿病孕妇的血清蛋白质组图谱
Sci Rep. 2022 May 24;12(1):8696. doi: 10.1038/s41598-022-12221-5.
10
Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.中国云南省布朗族人群中非常重要的药物基因变异体的遗传多态性
Pharmgenomics Pers Med. 2021 Dec 17;14:1647-1660. doi: 10.2147/PGPM.S327313. eCollection 2021.

本文引用的文献

1
Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism.子痫前期与血管紧张素转换酶 (ACE) I/D 和血管紧张素 II 型 1 受体 (AT1R) A1166C 多态性:与 ACE I/D 多态性的关联。
J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):174-80. doi: 10.1177/1470320312448950. Epub 2012 Jun 19.
2
Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.ACE I/D 基因多态性与糖尿病肾病终末期肾病患者的关系的荟萃分析。
Nephrology (Carlton). 2012 Jul;17(5):480-7. doi: 10.1111/j.1440-1797.2012.01592.x.
3
Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran.内皮型一氧化氮合酶 894T 与血管紧张素 II 转换酶 D 等位基因在伊朗西部库尔德人群中与糖尿病肾病并存。
Nephrology (Carlton). 2012 Feb;17(2):175-81. doi: 10.1111/j.1440-1797.2011.01533.x.
4
Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.MTHFR 1298C 与 ACE D 等位基因的相互作用增加了伊朗西部糖尿病肾病的风险。
DNA Cell Biol. 2012 Apr;31(4):553-9. doi: 10.1089/dna.2011.1364. Epub 2011 Sep 23.
5
Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects.血管紧张素转换酶基因多态性与糖尿病肾病的关系:一项包含 26580 例患者的荟萃分析。
J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):161-74. doi: 10.1177/1470320311417655. Epub 2011 Aug 2.
6
Preeclampsia in North Indian women: the contribution of genetic polymorphisms.北印度女性的子痫前期:基因多态性的作用
J Obstet Gynaecol Res. 2011 Oct;37(10):1335-41. doi: 10.1111/j.1447-0756.2010.01523.x. Epub 2011 May 12.
7
Role of the renin angiotensin system in diabetic nephropathy.肾素-血管紧张素系统在糖尿病肾病中的作用。
World J Diabetes. 2010 Nov 15;1(5):141-5. doi: 10.4239/wjd.v1.i5.141.
8
Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects.鉴定 NOS3、ET-1 和 RAS 中的基因变异,这些变异赋予 2 型糖尿病肥胖患者发生微血管病变的风险和保护作用。
Biochem Biophys Res Commun. 2011 Apr 15;407(3):486-90. doi: 10.1016/j.bbrc.2011.03.043. Epub 2011 Mar 21.
9
Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients.eNOS 多态性与 MTHFR 变异的相互作用增加了 2 型糖尿病患者发生糖尿病肾病及其进展的风险。
Mol Cell Biochem. 2011 Jul;353(1-2):23-34. doi: 10.1007/s11010-011-0770-0. Epub 2011 Mar 6.
10
The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.伊朗 II 型糖尿病伴微量白蛋白尿患者中因子 V Leiden 突变、ACE 基因多态性、血清 ACE 活性及对 ACE 抑制剂和血管紧张素 II 受体拮抗剂药物反应的频率。
Mol Biol Rep. 2011 Mar;38(3):2117-23. doi: 10.1007/s11033-010-0338-1. Epub 2010 Sep 19.